215 related articles for article (PubMed ID: 30192990)
1. All about CDR transporters: Past, present, and future.
Prasad R; Balzi E; Banerjee A; Khandelwal NK
Yeast; 2019 Apr; 36(4):223-233. PubMed ID: 30192990
[TBL] [Abstract][Full Text] [Related]
2. Emerging Mechanisms of Drug Resistance in Candida albicans.
Prasad R; Nair R; Banerjee A
Prog Mol Subcell Biol; 2019; 58():135-153. PubMed ID: 30911892
[TBL] [Abstract][Full Text] [Related]
3. Azole resistance in a
Khandelwal NK; Chauhan N; Sarkar P; Esquivel BD; Coccetti P; Singh A; Coste AT; Gupta M; Sanglard D; White TC; Chauvel M; d'Enfert C; Chattopadhyay A; Gaur NA; Mondal AK; Prasad R
J Biol Chem; 2018 Jan; 293(2):412-432. PubMed ID: 29158264
[TBL] [Abstract][Full Text] [Related]
4. Learning the ABC of oral fungal drug resistance.
Cannon RD; Holmes AR
Mol Oral Microbiol; 2015 Dec; 30(6):425-37. PubMed ID: 26042641
[TBL] [Abstract][Full Text] [Related]
5. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
[TBL] [Abstract][Full Text] [Related]
6. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
Sanglard D; Ischer F; Monod M; Bille J
Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
[TBL] [Abstract][Full Text] [Related]
7. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.
Saibabu V; Fatima Z; Singh S; Khan LA; Hameed S
J Mycol Med; 2020 Apr; 30(1):100921. PubMed ID: 31937429
[TBL] [Abstract][Full Text] [Related]
8. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: expression of a yeast multidrug transporter in baculovirus expression system.
Krishnamurthy S; Chatterjee U; Gupta V; Prasad R; Das P; Snehlata P; Hasnain SE; Prasad R
Yeast; 1998 Apr; 14(6):535-50. PubMed ID: 9605504
[TBL] [Abstract][Full Text] [Related]
9. FK506 Resistance of
Tanabe K; Bonus M; Tomiyama S; Miyoshi K; Nagi M; Niimi K; Chindamporn A; Gohlke H; Schmitt L; Cannon RD; Niimi M; Lamping E
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348662
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
11. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
[TBL] [Abstract][Full Text] [Related]
12. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells.
Tanida T; Okamoto T; Ueta E; Yamamoto T; Osaki T
J Antimicrob Chemother; 2006 Jan; 57(1):94-103. PubMed ID: 16291868
[TBL] [Abstract][Full Text] [Related]
14. Vacuolar Sequestration of Azoles, a Novel Strategy of Azole Antifungal Resistance Conserved across Pathogenic and Nonpathogenic Yeast.
Khandelwal NK; Wasi M; Nair R; Gupta M; Kumar M; Mondal AK; Gaur NA; Prasad R
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642932
[TBL] [Abstract][Full Text] [Related]
15. FK520 interacts with the discrete intrahelical amino acids of multidrug transporter Cdr1 protein and acts as antagonist to selectively chemosensitize azole-resistant clinical isolates of Candida albicans.
Nim S; Rawal MK; Prasad R
FEMS Yeast Res; 2014 Jun; 14(4):624-32. PubMed ID: 24628911
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of Cdr1, the drug-efflux pump conferring azole resistance in Candida species.
Pata J; Moreno A; Wiseman B; Magnard S; Lehlali I; Dujardin M; Banerjee A; Högbom M; Boumendjel A; Chaptal V; Prasad R; Falson P
Biochimie; 2024 May; 220():167-178. PubMed ID: 38158037
[TBL] [Abstract][Full Text] [Related]
18. Candida Efflux ATPases and Antiporters in Clinical Drug Resistance.
Prasad R; Rawal MK; Shah AH
Adv Exp Med Biol; 2016; 892():351-376. PubMed ID: 26721282
[TBL] [Abstract][Full Text] [Related]
19. Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p.
Shah AH; Rawal MK; Dhamgaye S; Komath SS; Saxena AK; Prasad R
Sci Rep; 2015 Jun; 5():11211. PubMed ID: 26053667
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity and drug resistance in Candida albicans and other yeast species. A review.
Mishra NN; Prasad T; Sharma N; Payasi A; Prasad R; Gupta DK; Singh R
Acta Microbiol Immunol Hung; 2007 Sep; 54(3):201-35. PubMed ID: 17896473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
